These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action. Canal CE Handb Exp Pharmacol; 2018; 252():227-260. PubMed ID: 29532180 [TBL] [Abstract][Full Text] [Related]
64. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes. Song J; Hanniford D; Doucette C; Graham E; Poole MF; Ting A; Sherf B; Harrington J; Brunden K; Stricker-Krongrad A Assay Drug Dev Technol; 2005 Dec; 3(6):649-59. PubMed ID: 16438660 [TBL] [Abstract][Full Text] [Related]
65. Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action. Dos Santos RG; Hallak JE; Baker G; Dursun S J Psychopharmacol; 2021 Apr; 35(4):453-458. PubMed ID: 33740877 [TBL] [Abstract][Full Text] [Related]
66. Role of the serotonin 5-HT(2A) receptor in learning. Harvey JA Learn Mem; 2003; 10(5):355-62. PubMed ID: 14557608 [TBL] [Abstract][Full Text] [Related]
67. d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology. De Gregorio D; Comai S; Posa L; Gobbi G Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27886063 [TBL] [Abstract][Full Text] [Related]
70. A non-hallucinogenic LSD analog with therapeutic potential for mood disorders. Lewis V; Bonniwell EM; Lanham JK; Ghaffari A; Sheshbaradaran H; Cao AB; Calkins MM; Bautista-Carro MA; Arsenault E; Telfer A; Taghavi-Abkuh FF; Malcolm NJ; El Sayegh F; Abizaid A; Schmid Y; Morton K; Halberstadt AL; Aguilar-Valles A; McCorvy JD Cell Rep; 2023 Mar; 42(3):112203. PubMed ID: 36884348 [TBL] [Abstract][Full Text] [Related]
71. Return of the lysergamides. Part II: Analytical and behavioural characterization of N Brandt SD; Kavanagh PV; Westphal F; Elliott SP; Wallach J; Colestock T; Burrow TE; Chapman SJ; Stratford A; Nichols DE; Halberstadt AL Drug Test Anal; 2017 Jan; 9(1):38-50. PubMed ID: 27265891 [TBL] [Abstract][Full Text] [Related]
72. Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a ß-arrestin2/Src/Akt signaling complex in vivo. Schmid CL; Bohn LM J Neurosci; 2010 Oct; 30(40):13513-24. PubMed ID: 20926677 [TBL] [Abstract][Full Text] [Related]
73. Effect of Hallucinogens on Unconditioned Behavior. Halberstadt AL; Geyer MA Curr Top Behav Neurosci; 2018; 36():159-199. PubMed ID: 28224459 [TBL] [Abstract][Full Text] [Related]
74. LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor. Halberstadt AL; Geyer MA Psychopharmacology (Berl); 2010 Feb; 208(2):179-89. PubMed ID: 19937319 [TBL] [Abstract][Full Text] [Related]
75. LSD and DOB: interaction with 5-HT2A receptors to inhibit NMDA receptor-mediated transmission in the rat prefrontal cortex. Arvanov VL; Liang X; Russo A; Wang RY Eur J Neurosci; 1999 Sep; 11(9):3064-72. PubMed ID: 10510170 [TBL] [Abstract][Full Text] [Related]